WallStSmart

Air Products and Chemicals Inc (APD)vsBioNexus Gene Lab Corp Common stock (BGLC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Air Products and Chemicals Inc generates 234594% more annual revenue ($12.46B vs $5.31M). APD leads profitability with a 16.9% profit margin vs -54.7%. APD earns a higher WallStSmart Score of 57/100 (C).

APD

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.0Quality: 3.5
Piotroski: 1/9Altman Z: 1.36

BGLC

Avoid

26

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 7.52
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APDSignificantly Overvalued (-89.1%)

Margin of Safety

-89.1%

Fair Value

$146.39

Current Price

$282.35

$135.96 premium

UndervaluedFair: $146.39Overvalued

Intrinsic value data unavailable for BGLC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APD2 strengths · Avg: 8.5/10
Market CapQuality
$62.19B9/10

Large-cap with strong market position

Operating MarginProfitability
23.6%8/10

Strong operational efficiency at 23.6%

BGLC3 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.5210/10

Safe zone — low bankruptcy risk

Areas to Watch

APD4 concerns · Avg: 3.5/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

P/E RatioValuation
29.5x4/10

Moderate valuation

Debt/EquityHealth
1.173/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

BGLC4 concerns · Avg: 2.5/10
Market CapQuality
$5.56M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-35.9%2/10

ROE of -35.9% — below average capital efficiency

Revenue GrowthGrowth
-98.9%2/10

Revenue declined 98.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : APD

The strongest argument for APD centers on Market Cap, Operating Margin. Profitability is solid with margins at 16.9% and operating margin at 23.6%.

Bull Case : BGLC

The strongest argument for BGLC centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : APD

The primary concerns for APD are PEG Ratio, P/E Ratio, Debt/Equity.

Bear Case : BGLC

The primary concerns for BGLC are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

APD profiles as a mature stock while BGLC is a turnaround play — different risk/reward profiles.

BGLC carries more volatility with a beta of 2.19 — expect wider price swings.

APD is growing revenue faster at 8.8% — sustainability is the question.

BGLC generates stronger free cash flow (-148,000), providing more financial flexibility.

Bottom Line

APD scores higher overall (57/100 vs 26/100), backed by strong 16.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Air Products and Chemicals Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Air Products and Chemicals, Inc. is an American international corporation whose principal business is selling gases and chemicals for industrial uses. Air Products' headquarters is in Allentown, Pennsylvania.

Visit Website →

BioNexus Gene Lab Corp Common stock

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.

Want to dig deeper into these stocks?